the obvious reason: their big-spending pharmaceutical advertisers would drop them like hot potatoes.
.
.
"the big unanswered question is concerns over safety in pregnancy," she says. cgrp levels are lower than normal in pregnant women who have
.
�now we know the astonishing truth that some patients are waiting a year or more just to get treatment. it�s simply not good enough.�
.
february 16, 2018
.
international
.